↓ Skip to main content

Celecoxib and Etoricoxib may reduce risk of ischemic stroke in patients with rheumatoid arthritis: A nationwide retrospective cohort study

Overview of attention for article published in Frontiers in Neurology, October 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter
19 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Celecoxib and Etoricoxib may reduce risk of ischemic stroke in patients with rheumatoid arthritis: A nationwide retrospective cohort study
Published in
Frontiers in Neurology, October 2022
DOI 10.3389/fneur.2022.1018521
Pubmed ID
Authors

Acer I-Hung Chen, Yung-Heng Lee, Wuu-Tsun Perng, Jeng-Yuan Chiou, Yu-Hsun Wang, Lichi Lin, James Cheng-Chung Wei, Hsi-Kai Tsou

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 18%
Other 1 9%
Lecturer 1 9%
Student > Doctoral Student 1 9%
Researcher 1 9%
Other 2 18%
Unknown 3 27%
Readers by discipline Count As %
Medicine and Dentistry 3 27%
Nursing and Health Professions 1 9%
Pharmacology, Toxicology and Pharmaceutical Science 1 9%
Agricultural and Biological Sciences 1 9%
Neuroscience 1 9%
Other 0 0%
Unknown 4 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 December 2022.
All research outputs
#3,457,715
of 26,014,510 outputs
Outputs from Frontiers in Neurology
#2,210
of 14,835 outputs
Outputs of similar age
#69,556
of 445,108 outputs
Outputs of similar age from Frontiers in Neurology
#53
of 796 outputs
Altmetric has tracked 26,014,510 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 14,835 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,108 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 796 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.